Product Overview
[Drug Name]
Generic Name: Vinpocetine Tablets
Trade Name: Tailiping
English Name: Vinpocetine Tablets
Chinese Pinyin: Changchunxiting Pian
[Ingredients]
The main ingredient of this product is Vinpocetine, whose chemical name is ethyl (13as, 13bs)-13a-ethyl-2,3,5,6-13a, 13bhexahydro-1H-indolo[3,2,1-de]pyridine[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid.
[Properties]
This product is a light pink film-coated tablet that appears white after removal of the film coating.
[Indications]
It is indicated for the treatment of sequelae of cerebral infarction, sequelae of cerebral hemorrhage, and cerebral arteriosclerosis.
[Dosage and Administration]
For oral administration, adults take 5 mg (one tablet) three times a day, or as directed by a physician.
[Adverse Reactions]
1. Rash, urticaria, and itching may sometimes occur; in these cases, the drug should be discontinued.
2. Abdominal pain, diarrhea, and loss of appetite may sometimes occur.
3. Dizziness, facial flushing, mild decrease in blood pressure, and tachycardia may occasionally occur.
4. Leukopenia and elevated S-GOT, S-GPT, r-GTP, AL-P, and blood urea nitrogen may sometimes occur.
[Contraindications]
Contraindicated during the acute phase of intracranial hemorrhage.
[Precautions]
1. Monitor blood counts during long-term use.
2. Once opened, use as soon as possible within the expiration date.
3. Use with caution in breastfeeding women; discontinue breastfeeding if necessary.
4. This product should be taken as directed by a physician.
[Use in Special Populations]
Precautions for Children:
Not yet available.
Precautions for Pregnancy and Lactation:
1. Contraindicated in pregnant women or women who may become pregnant.
2. Use with caution in breastfeeding women; discontinue breastfeeding if necessary.
Elderly Precautions:
Unknown.
[Drug Interactions]
This product should not be used with heparin.
[Pharmacological Actions]
This product is a cerebral vasodilator that inhibits phosphodiesterase activity, enhances the action of c-GMP, a messenger that relaxes vascular smooth muscle, and selectively increases cerebral blood flow. It also inhibits platelet aggregation, reduces blood viscosity, enhances red blood cell deformability, improves blood flow and microcirculation, promotes glucose uptake in brain tissue, increases cerebral oxygen consumption, and improves brain metabolism.
[Storage] Store tightly closed in a dry, light-proof place.
[Strength] 5 mg
[Packaging Size] 15 tablets/box.
[Expiry Life] 24 months.
[Approval Number] National Medicine Standard H33022342
[Manufacturer] Zhejiang Tailisen Pharmaceutical Co., Ltd.
